Data de publicação: 17/08/2021 - 16:53
Fiocruz will take on another challenge in the fight against COVID-19 with the production and supply of approximately 60 million antigen tests to the Ministry of Health (MS, the Portuguese acronym) by the end of 2021. Tests will be provided according to the demand of the ministry.
In addition to the production, Fiocruz will also be responsible for training the teams and providing technical and scientific assistance in the locations to be...
Notícias
Data de publicação: 17/08/2021 - 10:05
The British government wants to expand its scientific partnership with Fiocruz, especially in fields such as genomic sequencing, declared the minister counsellor of the British Embassy in Brazil, Melanie Hopkins, during a meeting with the president Nísia Trindade Lima, this Thursday (August, 12th). A month in office, the minister visited the Foundation accompanied by the consul general in Rio de Janeiro, Simon Wood.
British minister...
Notícias
Data de publicação: 09/08/2021 - 19:27
In the International Year of Health and Care Workers, this workforce is depleted. They have been the targets of applauses and assaults, seen old problems worsen, and become victims of the very COVID-19 they help fight. This panorama was outlined during the webinar Human Resources in Health in a Pandemic, promoted by the Fiocruz Global Health Center (CRIS/Fiocruz), on August 4th. With Francisco Eduardo Campos mediation, a public health and human...
Notícias
Data de publicação: 19/08/2021 - 10:10
In Manaus, the estimated population of pregnant women is 28.4 thousand, and of postpartum women, 4.7 thousand. According to data from the COVID-19 Manaus Vaccinometer, so far, only 6,606 pregnant women and 1,680 mothers have received the first dose of the vaccine. Coordinated by researchers from the Leônidas & Maria Deane Institute (Fiocruz Amazônia) and the Universidade Federal do Amazonas (UFAM), a study is investigating the...
Notícias
Data de publicação: 23/08/2021 - 10:04
The post-pandemic perspectives on Agenda 2030 in relation to issues such as health, human rights, and climate were addressed by the Advanced Seminars of the Fiocruz Global Health Center (CRIS/Fiocruz) this Wednesday (August, 18th). The event Agenda 2030: global stocktake and post-pandemic perspectives presented an updated assessment of the Sustainable Development Goals (SDGs) at global, regional and national levels, pointing out criticisms and...
Notícias
Data de publicação: 25/08/2021 - 12:33
Effectiveness studies of COVID-19 vaccines have demonstrated the immunization importance for protection against severe cases and hospitalization against the new variants. In June, data showed a 92% effectiveness of the AstraZeneca vaccine for hospitalizations against the Delta variant. Now, a new study coordinated by Oxford University in the United Kingdom points out that the Pfizer and AstraZeneca vaccines, this one produced in Brazil by...
Notícias
Data de publicação: 30/09/2021 - 14:08
By means of its Immunobiological Technology Institute (Bio-Manguinhos), last Monday (September 27th) Fiocruz ended the production of the first batches called pre-validation batches of the national Active Pharmaceutical Ingredient (API) for the COVID-19 vaccine. The ingredient will now be submitted to quality control tests at the institution to then be sent to the final processing phase of the vaccine. The first pre-validation batch, which was...
Notícias
Data de publicação: 21/09/2021 - 15:20
Researcher Jorge Bermudez, chief of the Department of Medicines Policy and Pharmaceutical Services at the Sergio Arouca National School of Public Health (ENSP/Fiocruz, in the Portuguese acronym), is now a member of the Technical Advisory Group (TAG) created to advise the World Health Organization (WHO) in scientific, technical and strategic issues related to COVID-19 Technology Access Pool (C-TAP). C-TAP is a solidarity mechanism launched...
Notícias
Data de publicação: 02/09/2021 - 17:05
A study conducted by Brazilian researchers shows how age influences the effectiveness of the two main immunizers used in the country against COVID-19. Submitted as a preprint in MedRxiv, the study Influence of age on effectiveness and duration of protection in the Oxford/AstraZeneca and CoronaVac vaccines involved more than 75 million immunized people, becoming the largest study conducted with the two immunizers and may serve as a basis for...
Notícias
Data de publicação: 04/10/2021 - 10:54
The COVID-19 pandemic was one of the main subjects discussed at two meetings that drew the attention of the entire world and of the region last week. While chiefs of state and of government debated the effects of the disease at the 76th General Assembly of the United Nations, at the 59th Board of Directors and 73rd Session of the Regional Committee of the World Health Organization (WHO) for the Americas, organized by the Pan-American Health...
Notícias
Data de publicação: 25/06/2021 - 10:54
A study developed in partnership between Fiocruz Pernambuco, the Federal Rural University of Pernambuco (UFRPE) and the Federal Institute of Paraíba (IFPB) carried out an investigation on the evolution over time of the daily numbers of deaths by COVID-19, taking into account the scenario in 43 countries. Using physical approaches and information theory techniques, the researchers achieved results that give scientific evidence as for the...
Notícias
Data de publicação: 12/07/2021 - 12:37
A diagnostic kit to detect the new coronavirus that can be employed directly by basic health units, providing a result in up to 45 minutes, at a low cost and with high accuracy. The innovation, which may help fight COVID-19, has had its patent deposited after a year of work by researchers of the Oswaldo Cruz Institute (IOC/Fiocruz), the Federal University of Santa Catarina (UFSC), and the Federal Institute of Santa Catarina (IFSC), in a...
Notícias
Data de publicação: 23/06/2021 - 09:56
Fiocruz was elected a member of the Joint Coordinating Board of the WHO’s Special Program for Research and Training in Tropical Diseases (TDR). The election took place last Thursday (June 17), during the Council’s 44th meeting, giving the Foundation a mandate spanning from January 1st, 2022, to December 31st, 2025.
“This acknowledgment of Fiocruz is a momentous event. Together with the Council, the Foundation will seek to go...
Notícias
Data de publicação: 26/07/2021 - 17:58
Fiocruz president, Nísia Trindade Lima, will be receiving the degree of Knight of Legion of Honor, France’s order of merit (Ordre National de la Légion d’Honneur), as an acknowledgment of her career in the world of science and health, in particular in the fight against the COVID-19 pandemic.
The ambassador of France, Brigitte Collet, and president Nísia Trindade at the meeting where they discussed health...
Notícias
Data de publicação: 28/06/2021 - 17:34
Over the past week, the four central units of large processing of molecular tests (RT-PCR) for Covid-19 coordinated by the Ministry of Health, with the support of Fiocruz, achieved the equivalent of 7 million samples processed, which represents about 40% of all testing done in the public system. In addition to processing the tests, Fiocruz is also responsible for their production, having already concluded its committment, signed in 2020 with the...
Notícias
Data de publicação: 01/07/2021 - 10:57
In 2020, research operations did not take place in Antarctica due to the restrictions enforced by the COVID-19 pandemic. At the same time, the current public health crisis has shown the importance of knowledge in health, of surveillance, and of an integration of human, environmental, and animal health, in order to respond to present and future challenges. For this reason, teams are preparing for new research missions this year and are already...
Notícias
Data de publicação: 26/07/2021 - 19:07
The largest set of favelas in Rio de Janeiro, with about 140,000 inhabitants, Maré will be the home of a study led by Fiocruz on the impact of COVID-19 vaccination on its population. The initiative is a collaboration between the Networks of Maré, Rio de Janeiro’s City Hall by means of the Municipal Secretariat of Health, and Fiocruz. Taking into account the peculiarities in territories that include favelas and peripheral...
Notícias
Data de publicação: 02/12/2016 - 10:28
Nagoya Protocol: Reference Documents
The Nagoya Protocol is the international agreement that regulates the Access and Benefit Sharing. That is, it establishes guidelines for commercial relations between the provider country of the genetic resources and the user country, covering aspects such as royalty payments, establishment of joint ventures, the right to technology transfer and training.
The protocol was created by the Conference of the...
Páginas Institucionais (antigas)
Data de publicação: 16/07/2021 - 18:24
Data from Relatório Luz 2021 show that Brazil did not make any progress in the 17 Sustainable Development Goals (SDG) of United Nations’ 2030 Agenda. The 5th edition of the report was published on Monday (July 12th), in a public meeting of the Chamber of Deputies.
The document is prepared by the Civil Society Working Group, which consists of 57 organizations and boards from all over the country. One hundred and six...
Notícias
Data de publicação: 16/07/2021 - 13:42
The dispersion of diseases in the Amazon is directly related to the agricultural development trajectory of municipalities and the loss of biodiversity. Malaria is prevalent in municipalities with an agro-extractivist profile and with forest cover, that is, half of the Amazon territory. Dengue and chikungunya occur more frequently in municipalities of recent urban expansion, such as on the southern edge of the Amazon in transition to the Cerrado...
Notícias
Data de publicação: 30/06/2021 - 13:02
A recently published study, with the participation of the Oswaldo Cruz Foundation - Fiocruz, suggests that the Delta variant of the new coronavirus, first detected in India, may increase the risk of reinfection. The research shows that the serum of people previously infected by other strains is less powerful against this viral variant. The problem is markedly observed among individuals previously infected by the Gamma variant, originally...
Notícias
Data de publicação: 07/07/2021 - 10:54
Economy or health? This false dichotomy used as an argument against pandemic control measures in Brazil has lost yet another nuance. If decision-makers were guided by ideal information that allowed them to adopt social distancing measures at the right moment and in the right dose, more lives could be saved, and the economic impact could be reduced during the pandemic. To make this possible, a predictive control system was developed within the...
Notícias
Data de publicação: 28/06/2021 - 10:34
Cooperation between the so-called Global South countries took a hard hit during the COVID-19 pandemic, suffering backtracks due to political and ideological issues in the past few years, but it has the potential to help these nations overcome the public health crisis with a sustainable recovery. These were some of the reflections raised during the South-South Cooperation seminar, diplomacy in health and pandemic that the Fiocruz Global Heath...
Notícias
Data de publicação: 29/07/2021 - 11:19
Three projects led by Fiocruz researchers are among the ten selected worldwide by the Grand Challenges ICODA COVID-19 Data Science, an initiative that supports health data projects to respond more accurately to the pandemic and possible challenges in the future. With support from the Bill & Melinda Gates Foundation, the Minderoo Foundation, and Microsoft's AI for Health program, they will receive a fund of US$100,000 for their...
Notícias